Original Article

An In Silico Analysis Identified FZD9 as a Potential Prognostic Biomarker in Triple-Negative Breast Cancer Patients
  • Daniel Rodrigues de Bastos
  • Mércia Patrícia Ferreira Conceição
  • Ana Paula Picaro Michelli
  • Jean Michel Rocha Sampaio Leite
  • Rafael André da Silva
  • Ricardo Cesar Cintra
  • Jeniffer Johana Duarte Sanchez
  • Cesar Augusto Sam Tiago Vilanova-Costa
  • Antonio Márcio Teodoro Cordeiro Silva
Eur J Breast Health 2021; 17: 42-52 DOI: 10.4274/ejbh.2020.5804 PMID:33796830
Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project
  • Vahit Özmen
  • Sibel Ö. Gürdal
  • Neslihan Cabioğlu
  • Beyza Özcinar
  • A. Nilüfer Özaydın
  • Arda Kayhan
  • Erkin Arıbal
  • Cennet Sahin
  • Pınar Saip
  • Oğuzhan Alagöz
Eur J Breast Health 2017; 13: 117-122 DOI: 10.5152/ejbh.2017.3528
Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle- Income Country, Turkey: Results of a Prospective Multicenter Study
  • Vahit Özmen
  • Burcu Çakar
  • Erhan Gökmen
  • Mustafa Özdoğan
  • Nilufer Güler
  • Cihan Uras
  • Engin Ok
  • Orhan Demircan
  • Abdurrahman Işıkdoğan
  • Pınar Saip
Eur J Breast Health 2019; 15: 183-190 DOI: 10.5152/ejbh.2019.4761
Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey
  • Carole Mathelin
  • Shanti Ame
  • Stanley Anyanwu
  • Eli Avisar
  • Wahib Mohcen Boubnider
  • Katrin Breitling
  • Hannah Ayettey Anie
  • José Carlos Conceição
  • Veronique Dupont
  • Elisabeth Elder
  • Constanze Elfgen
  • Tony Elonge
  • Edelmiro Iglesias
  • Shigeru Imoto
  • Lydia Ioannidou-Mouzaka
  • Elisabeth A Kappos
  • Martin Kaufmann
  • Michael Knauer
  • Franck Luzuy
  • Marko Margaritoni
  • Mamadou Mbodj
  • Alexander Mundinger
  • Ruben Orda
  • Valerijus Ostapenko
  • Serdar Özbaş
  • Vahit Özmen
  • Olivia Pagani
  • Tadeusz Pieńkowski
  • Schlomo Schneebaum
  • Ekaterina Shmalts
  • Ashraf Selim
  • Zotov Pavel
  • Massimo Lodi
  • Maurício Magalhales Costa
Eur J Breast Health 2021; 17: 188-196 DOI: 10.4274/ejbh.galenos.2021.2021-1-4 PMID:33870120
The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future
  • Carole Mathelin
  • Massimo Lodi
  • Khalid Alghamdi
  • Bolivar Arboleda-Osorio
  • Eli Avisar
  • Stanley Anyanwu
  • Mohcen Boubnider
  • Mauricio Maghales Costa
  • Elisabeth Elder
  • Tony Elonge
  • Luiz Gebrim
  • Xishan Hao
  • Shigeru Imoto
  • Esther Meka
  • Michel Mouelle
  • Alexander Mundinger
  • Valerijus Ostapenko
  • Serdar Özbaş
  • Tolga Özmen
  • Vahit Özmen
  • Tadeusz Pienkowski
  • Gustavo Sarria
  • Ashraf Selim
  • Vladimir Semiglazov
  • Schlomo Schneebaum
Eur J Breast Health 2022; 18: 205-221 DOI: 10.4274/ejbh.galenos.2022.2022-4-3 PMID:35855198
Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach
  • Rukiye Numanoğlu Tekin
  • Meltem Saygılı
Eur J Breast Health 2019; 15: 242-248 DOI: 10.5152/ejbh.2019.4909

Review

New Frontiers for Fairer Breast Cancer Care in a Globalized World
  • Didier Verhoeven
  • Claudia Allemani
  • Cary Kaufman
  • Sabine Siesling
  • Manuela Joore
  • Etienne Brain
  • Mauricio Magalhães Costa
Eur J Breast Health 2021; 17: 86-94 DOI: 10.4274/ejbh.galenos.2021.2021-1-1 PMID:33870106
360 Health Analysis (H360) – A Proposal for an Integrated Vision of Breast Cancer in Portugal
  • Sara Coelho
  • Inês Brandão Rego
  • Maria Rita Dionísio
  • Joana Cavaco-Silva
  • Patrícia Miguel Semedo
  • Francisco Pavão
  • Ricardo Baptista Leite
  • Luís Costa
Eur J Breast Health 2020; 16: 91-98 DOI: 10.5152/ejbh.2020.5144
Risk Reduction Strategies in Breast Cancer Prevention
  • Mauricio Costa
  • Paula Saldanha
Eur J Breast Health 2017; 13: 103-112 DOI: 10.5152/ejbh.2017.3583
Value-Based Quality Care for Breast Cancer: More Than Guidelines
  • Nuh Zafer Cantürk
  • Bahadır M. Güllüoğlu
Eur J Breast Health 2021; 17: 297-301 DOI: 10.4274/ejbh.galenos.2021.6333 PMID:34651106